Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.480
+0.090 (6.47%)
At close: Oct 23, 2025, 4:00 PM EDT
1.420
-0.060 (-4.05%)
After-hours: Oct 23, 2025, 4:22 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $18.95 million as of October 23, 2025.
Market Cap
18.95M
Enterprise Value
19.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $18.95M, a decrease of -47.64%. That is a compound annual growth rate of -97.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 20.20M | - |
| Oct 16, 2025 | 20.20M | -9.01% |
| Oct 15, 2025 | 22.20M | -2.63% |
| Oct 14, 2025 | 22.80M | -2.56% |
| Oct 13, 2025 | 23.40M | 5.41% |
| Oct 10, 2025 | 22.20M | -7.88% |
| Oct 9, 2025 | 24.10M | -1.63% |
| Oct 8, 2025 | 24.50M | -2.39% |
| Oct 7, 2025 | 25.10M | -1.18% |
| Oct 6, 2025 | 25.40M | 11.89% |
| Oct 3, 2025 | 22.70M | -3.81% |
| Oct 2, 2025 | 23.60M | 8.26% |
| Oct 1, 2025 | 21.80M | - |
| Sep 30, 2025 | 21.80M | -6.84% |
| Sep 29, 2025 | 23.40M | 1.74% |
| Sep 26, 2025 | 23.00M | 0.88% |
| Sep 25, 2025 | 22.80M | -6.94% |
| Sep 24, 2025 | 24.50M | 2.08% |
| Sep 23, 2025 | 24.00M | -6.61% |
| Sep 22, 2025 | 25.70M | -5.51% |
| Sep 19, 2025 | 27.20M | -1.45% |
| Sep 18, 2025 | 27.60M | -1.08% |
| Sep 17, 2025 | 27.90M | -0.71% |
| Sep 16, 2025 | 28.10M | -1.06% |
| Sep 15, 2025 | 28.40M | 1.43% |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |